Disease management
The startup plans to use the funds to develop its platform, launch a virtual care center and expand its care team.
The virtual care company plans to add devices that can transmit metrics like blood pressure or glucose levels to MDLIVE's patient portal later this year.
The company plans to use the new funds to help fuel its FDA submission.
Cofounder and CEO Matthew Stoudt discusses AppliedVR's De Novo clearance from November, what's next for the company and the biggest trends from 2021.
It displays health data from bluetooth-enabled medical devices in video teleconsultations.
It is the global multilingual version of the Japanese device NouKNOW.
2022 Look Ahead
Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue this year, and that the push toward interoperability will be critical for the space.
SugoSure targets patients with type 2 diabetes below 65 years old.
The consumer app enables users to monitor their own heart rhythm round the clock.
Impeto’s SUDOSCAN technology for monitoring peripheral neuropathies is included in Withings’ recently announced Body Scan smart scale.